Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies - Past, Present, and Future.

Spaans JN, Goss GD.

Front Oncol. 2014 Aug 27;4:233. doi: 10.3389/fonc.2014.00233. eCollection 2014. Review.

PMID:
25221748
[PubMed]
Free PMC Article
2.

Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada.

Cressman S, Lam S, Tammemagi MC, Evans WK, Leighl NB, Regier DA, Bolbocean C, Shepherd FA, Tsao MS, Manos D, Liu G, Atkar-Khattra S, Cromwell I, Johnson MR, Mayo JR, McWilliams A, Couture C, English JC, Goffin J, Hwang DM, Puksa S, Roberts H, Tremblay A, MacEachern P, Burrowes P, Bhatia R, Finley RJ, Goss GD, Nicholas G, Seely JM, Sekhon HS, Yee J, Amjadi K, Cutz JC, Ionescu DN, Yasufuku K, Martel S, Soghrati K, Sin DD, Tan WC, Urbanski S, Xu Z, Peacock SJ; On behalf of the Pan-Canadian Lung Cancer Early Detection Study Team.

J Thorac Oncol. 2014 Aug 7. [Epub ahead of print]

PMID:
25105438
[PubMed - as supplied by publisher]
3.

Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer.

Spaans JN, Goss GD.

Front Oncol. 2014 Jul 23;4:190. doi: 10.3389/fonc.2014.00190. eCollection 2014. Review.

PMID:
25101246
[PubMed]
Free PMC Article
4.

Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25.

Cheung P, Faria S, Ahmed S, Chabot P, Greenland J, Kurien E, Mohamed I, Wright JR, Hollenhorst H, de Metz C, Campbell H, Vu TT, Karvat A, Wai ES, Ung YC, Goss G, Shepherd FA, O'Brien P, Ding K, O'Callaghan C.

J Natl Cancer Inst. 2014 Jul 29;106(8). pii: dju164. doi: 10.1093/jnci/dju164. Print 2014 Aug.

PMID:
25074417
[PubMed - indexed for MEDLINE]
5.

Adult c-Kit(+) progenitor cells are necessary for maintenance and regeneration of olfactory neurons.

Goldstein BJ, Goss GM, Hatzistergos KE, Rangel EB, Seidler B, Saur D, Hare JM.

J Comp Neurol. 2014 Jul 19. doi: 10.1002/cne.23653. [Epub ahead of print]

PMID:
25044230
[PubMed - as supplied by publisher]
6.

Phosphate absorption across multiple epithelia in the Pacific hagfish (Eptatretus stoutii).

Schultz AG, Guffey SC, Clifford AM, Goss GG.

Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15;307(6):R643-52. doi: 10.1152/ajpregu.00443.2013. Epub 2014 Jun 18.

PMID:
24944247
[PubMed - in process]
7.

Acid-sensing ion channels are involved in epithelial Na+ uptake in the rainbow trout Oncorhynchus mykiss.

Dymowska AK, Schultz AG, Blair SD, Chamot D, Goss GG.

Am J Physiol Cell Physiol. 2014 Aug 1;307(3):C255-65. doi: 10.1152/ajpcell.00398.2013. Epub 2014 Jun 4.

PMID:
24898589
[PubMed - in process]
8.

Defensive slime formation in Pacific hagfish requires Ca2+- and aquaporin-mediated swelling of released mucin vesicles.

Herr JE, Clifford AM, Goss GG, Fudge DS.

J Exp Biol. 2014 Jul 1;217(Pt 13):2288-96. doi: 10.1242/jeb.101584. Epub 2014 Apr 15.

PMID:
24737755
[PubMed - in process]
9.

Effects of anionic polyacrylamide products on gill histopathology in juvenile rainbow trout (Oncorhynchus mykiss).

Kerr JL, Lumsden JS, Russell SK, Jasinska EJ, Goss GG.

Environ Toxicol Chem. 2014 Jul;33(7):1552-62. doi: 10.1002/etc.2582. Epub 2014 May 27.

PMID:
24648306
[PubMed - in process]
10.

Widespread nanoparticle-assay interference: implications for nanotoxicity testing.

Ong KJ, MacCormack TJ, Clark RJ, Ede JD, Ortega VA, Felix LC, Dang MK, Ma G, Fenniri H, Veinot JG, Goss GG.

PLoS One. 2014 Mar 11;9(3):e90650. doi: 10.1371/journal.pone.0090650. eCollection 2014.

PMID:
24618833
[PubMed - in process]
Free PMC Article
11.

Understanding interactions of functionalized nanoparticles with proteins: a case study on lactate dehydrogenase.

Stueker O, Ortega VA, Goss GG, Stepanova M.

Small. 2014 May 28;10(10):2006-21. doi: 10.1002/smll.201303639. Epub 2014 Mar 3.

PMID:
24591162
[PubMed - in process]
12.

Improving access to lung cancer treatment in northern Canada: the role of oral molecularly targeted agents.

Spaans JN, Asmis TR, Alvarez GG, Goss GD.

CMAJ. 2014 Apr 15;186(7):485-6. doi: 10.1503/cmaj.131011. Epub 2014 Feb 24. Review. No abstract available.

PMID:
24566641
[PubMed - indexed for MEDLINE]
13.

Time course of the acute response of the North Pacific spiny dogfish shark (Squalus suckleyi) to low salinity.

Guffey SC, Goss GG.

Comp Biochem Physiol A Mol Integr Physiol. 2014 May;171:9-15. doi: 10.1016/j.cbpa.2014.02.004. Epub 2014 Feb 8.

PMID:
24518388
[PubMed - in process]
14.

NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancer.

Ellis PM, Shepherd FA, Laurie SA, Goss GD, Olivo M, Powers J, Seymour L, Bradbury PA.

J Thorac Oncol. 2014 Mar;9(3):410-3. doi: 10.1097/JTO.0000000000000058.

PMID:
24518092
[PubMed - in process]
15.

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29.

Laurie SA, Solomon BJ, Seymour L, Ellis PM, Goss GD, Shepherd FA, Boyer MJ, Arnold AM, Clingan P, Laberge F, Fenton D, Hirsh V, Zukin M, Stockler MR, Lee CW, Chen EX, Montenegro A, Ding K, Bradbury PA.

Eur J Cancer. 2014 Mar;50(4):706-12. doi: 10.1016/j.ejca.2013.11.032. Epub 2013 Dec 17.

PMID:
24360368
[PubMed - indexed for MEDLINE]
16.

Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I study.

Bar J, Spencer S, Morgan S, Brooks L, Cunningham D, Robertson J, J├╝rgensmeier JM, Goss GD.

Clin Colorectal Cancer. 2014 Mar;13(1):46-53. doi: 10.1016/j.clcc.2013.11.002. Epub 2013 Nov 13.

PMID:
24355210
[PubMed - in process]
17.

Effects of polymer-coated metal oxide nanoparticles on goldfish (Carassius auratus L.) neutrophil viability and function.

Ortega VA, Katzenback BA, Stafford JL, Belosevic M, Goss GG.

Nanotoxicology. 2013 Dec 9. [Epub ahead of print]

PMID:
24313973
[PubMed - as supplied by publisher]
18.

Extrabranchial mechanisms of systemic pH recovery in hagfish (Eptatretus stoutii).

Clifford AM, Guffey SC, Goss GG.

Comp Biochem Physiol A Mol Integr Physiol. 2014 Feb;168:82-9. doi: 10.1016/j.cbpa.2013.11.009. Epub 2013 Nov 26.

PMID:
24291660
[PubMed - indexed for MEDLINE]
19.

Adult human nasal mesenchymal-like stem cells restore cochlear spiral ganglion neurons after experimental lesion.

Bas E, Van De Water TR, Lumbreras V, Rajguru S, Goss G, Hare JM, Goldstein BJ.

Stem Cells Dev. 2014 Mar 1;23(5):502-14. doi: 10.1089/scd.2013.0274. Epub 2013 Dec 4.

PMID:
24172073
[PubMed - in process]
20.

A phase II trial of saracatinib, an inhibitor of src kinases, in previously-treated advanced non-small-cell lung cancer: the princess margaret hospital phase II consortium.

Laurie SA, Goss GD, Shepherd FA, Reaume MN, Nicholas G, Philip L, Wang L, Schwock J, Hirsh V, Oza A, Tsao MS, Wright JJ, Leighl NB.

Clin Lung Cancer. 2014 Jan;15(1):52-7. doi: 10.1016/j.cllc.2013.08.001. Epub 2013 Oct 26.

PMID:
24169259
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk